glp-1 drugs mounjaro Could Weight Loss Also Treat or Prevent Chronic Diseases? GLP-1 Medications for Weight Loss
Description
More than 15 new obesity medications are expected to gain approval over the next five years
Patients who started tirzepatide but discontinued before reaching 10 mg lost 8.1% of baseline weight
These factors indicate that the GLP-1 RA group is more severely affected by diabetes compared to the DPP-4i group, and the GLP-1 RA group may thus be subject to residual confounding associated with higher fracture risk
Clinical syndrome and intracranial pressure
Merative MarketScan, [email protected])
